110 related articles for article (PubMed ID: 8590957)
1. An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency.
Garry P; Collins P; Devlin JG
Eur J Endocrinol; 1996 Jan; 134(1):61-6. PubMed ID: 8590957
[TBL] [Abstract][Full Text] [Related]
2. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
[TBL] [Abstract][Full Text] [Related]
3. The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial.
Nolte W; Rädisch C; Armstrong VW; Hüfner M; von zur Mühlen A
Eur J Endocrinol; 1997 Nov; 137(5):459-66. PubMed ID: 9405024
[TBL] [Abstract][Full Text] [Related]
4. The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients.
Russell-Jones DL; Watts GF; Weissberger A; Naoumova R; Myers J; Thompson GR; Sönksen PH
Clin Endocrinol (Oxf); 1994 Sep; 41(3):345-50. PubMed ID: 7955441
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study.
Christ ER; Cummings MH; Lumb PJ; Crook MA; Sönksen PH; Russell-Jones DL
Clin Endocrinol (Oxf); 1999 Aug; 51(2):173-9. PubMed ID: 10468987
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency.
Cuneo RC; Salomon F; Watts GF; Hesp R; Sönksen PH
Metabolism; 1993 Dec; 42(12):1519-23. PubMed ID: 8246764
[TBL] [Abstract][Full Text] [Related]
7. Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.
Sesmilo G; Biller BM; Llevadot J; Hayden D; Hanson G; Rifai N; Klibanski A
Ann Intern Med; 2000 Jul; 133(2):111-22. PubMed ID: 10896637
[TBL] [Abstract][Full Text] [Related]
8. Increased serum lipoprotein(a) concentrations after growth hormone (GH) treatment in patients with isolated GH deficiency.
O'Halloran DJ; Wieringa G; Tsatsoulis A; Shalet SM
Ann Clin Biochem; 1996 Jul; 33 ( Pt 4)():330-4. PubMed ID: 8836391
[TBL] [Abstract][Full Text] [Related]
9. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
[TBL] [Abstract][Full Text] [Related]
10. HDL-cholesterol reductions associated with adult growth hormone replacement.
Leese GP; Wallymahmed M; VanHeyningen C; Tames F; Wieringa G; MacFarlane IA
Clin Endocrinol (Oxf); 1998 Nov; 49(5):673-7. PubMed ID: 10197085
[TBL] [Abstract][Full Text] [Related]
11. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.
Beshyah SA; Henderson A; Niththyananthan R; Skinner E; Anyaoku V; Richmond W; Sharp P; Johnston DG
J Clin Endocrinol Metab; 1995 Feb; 80(2):356-63. PubMed ID: 7852490
[TBL] [Abstract][Full Text] [Related]
12. The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone-deficient adults.
Webster JM; Stewart M; al-Maskari M; Osman I; Kendall-Taylor P; Mitcheson J; Laker MF
Atherosclerosis; 1997 Aug; 133(1):115-21. PubMed ID: 9258415
[TBL] [Abstract][Full Text] [Related]
13. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.
Colao A; di Somma C; Cuocolo A; Spinelli L; Tedesco N; Pivonello R; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2001 May; 86(5):1874-81. PubMed ID: 11344175
[TBL] [Abstract][Full Text] [Related]
14. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Shalet SM
Clin Endocrinol (Oxf); 1999 Jun; 50(6):749-57. PubMed ID: 10468947
[TBL] [Abstract][Full Text] [Related]
15. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
[TBL] [Abstract][Full Text] [Related]
16. Low dose continuously infused growth hormone results in increased lipoprotein(a) and decreased low density lipoprotein cholesterol concentrations in middle-aged men.
Oscarsson J; Ottosson M; Wiklund O; Mårin P; Vikman-Adolfsson K; Björntorp P; Edén S
Clin Endocrinol (Oxf); 1994 Jul; 41(1):109-16. PubMed ID: 8050123
[TBL] [Abstract][Full Text] [Related]
17. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
Colao A; di Somma C; Pivonello R; Cuocolo A; Spinelli L; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
[TBL] [Abstract][Full Text] [Related]
18. Changes in adiposity and excess body weight correlate with growth responses but not with decreases in low-density lipoprotein cholesterol levels during GH treatment in GH-deficient children.
Kuromaru R; Kohno H; Hara T
Clin Endocrinol (Oxf); 2002 Jun; 56(6):799-803. PubMed ID: 12072051
[TBL] [Abstract][Full Text] [Related]
19. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
[TBL] [Abstract][Full Text] [Related]
20. Short and long-term effects of growth hormone treatment on lipid, lipoprotein, and apolipoprotein levels in short normal children.
Azzarito C; Boiardi L; Zini M; Agosti A; Biacchessi M; Biagi R; Portioli I
Horm Metab Res; 1994 Sep; 26(9):432-5. PubMed ID: 7835828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
